The Honest Apothecary

MAY 3, 2023

Here I share some of the latest news, articles, editorials, or blog posts that fall generally under the theme of Pharma or healthcare. ” STAT NEWS. Lily’s donanemab slows Alzheimer’s progression In good news for Eli Lily, their investigational trial of donanemab showed a slowing of cognitive decline by 35%.

Specialty Pharmacies 105

Specialty Pharmacies Insurance Hospitals 105

pharmaphorum

MAY 24, 2021

Germany is lagging behind other countries in the adoption of digital health, including Spain and the US, according to a new survey carried out on behalf of drugmaker Fresenius. . The US was way out in front when asked about video consultations, with 22% of people saying they had access to remote meetings with doctors.

Medical Records 142

Medical Records 142

pharmaphorum

OCTOBER 23, 2020

Novartis is opening a new digital health innovation hub in Canada to help develop “scalable, digital solutions” for patients and healthcare providers. The company has established centres in the US, UK, France and India. The institute formed a strategic alliance with Novartis in 2019.

130

130

Pharmaceutical Technology

NOVEMBER 22, 2022

Drug shortages continue to affect medical care in healthcare systems, and experts tell us that supply bottlenecks for cardiovascular drugs are particularly concerning. Also in this issue, we explore how European countries plan to use electronic health records to improve health-related decision-making.

93

93

pharmaphorum

JANUARY 17, 2022

GlaxoSmithKline (GSK) claims it has rejected three unsolicited, conditional and non-binding proposals from Unilever to acquire GSK Consumer Healthcare in a deal worth approximately $68.4 The Consumer Healthcare business is a Joint Venture between GSK and Pfizer, with GSK holding a majority controlling interest of 68% and Pfizer 32%.

113

113

PharmaShots

MAY 25, 2023

Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com Shots: The EMA has accepted the MAA for the proposed biosimilar denosumab (Prolia & Xgeva) indicated for treating multiple indications incl.

49

49

European Pharmaceutical Review

OCTOBER 14, 2022

Amgen’s 2022 market report has detailed how competition has driven savings across healthcare, estimating that a considerable number of biologics will be in competition with biosimilars in five to 10 years. More interchangeable biosimilars are estimated to be approved and launched in the US in the next few years.

FDA 78

FDA 78

Hospital Pharmacy Europe

SEPTEMBER 1, 2023

The subcutaneous anti-PD-L1 cancer immunotherapy atezolizumab (brand name Tecentriq subcutaneous (SC)) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA), paving the way for its use in the NHS in England, its manufacturer Roche has announced.

Chemotherapy 98

Chemotherapy Hospitals FDA 98

PQA

MARCH 22, 2024

Have you made your plans to join us at the 2024 PQA Annual Meeting, May 14-16, in Baltimore? Evaluating Community Pharmacy Quality The Community Pharmacy Enhanced Service Network (CPESN) special purpose network, CPESN Health Equity, is currently using the Choose My Pharmacy system across their entire membership. hours of pharmacy CE.

Health and Personal Care Stores 40

Health and Personal Care Stores Community Pharmacies Medication Delivery Immunization 40

PharmaShots

FEBRUARY 14, 2023

Shots: The company reported the commercial availability of the first microbiome-based treatment Rebyota in the US to prevent the recurrence of C. vs 44.8%) The company is committed to making Rebyota accessible to patients & healthcare providers & REBYOTA CONNECT program offers guidance to healthcare providers.

FDA 40

FDA 40

European Pharmaceutical Review

FEBRUARY 2, 2023

AMJEVITA (adalimumab-atto), a biosimilar to Humira ® (adalimumab), is now available in the US. Amgen’s AMJEVITA was the first biosimilar to Humira approved by the US Food and Drug Administration (FDA), in 2016. Five are FDA-approved in the US and three are approved in the European Union (EU).

FDA 83

FDA 83

Pharmaceutical Technology

DECEMBER 27, 2022

The healthcare industry saw its share of ups and downs in 2022. Our response to the worldwide pandemic evolved over time, and so did the needs of the sector and the people relying on healthcare companies to deliver solutions. Tracking the news. Tracking drug development. See you in 2023!

Vaccines 122

Vaccines 122

pharmaphorum

OCTOBER 14, 2022

has announced a $168 million Series B financing, led by global venture capital firm General Catalyst, an active investor in the healthcare sector. The Series B financing includes participation from all Series A investors and new investment from Fidelity Management & Research Company and T. Biotech company Odyssey Therapeutics, Inc.

101

101

pharmaphorum

FEBRUARY 17, 2021

John Singer discusses the disbanding of Haven, the joint healthcare venture by Amazon, JP Morgan and Berkshire Hathaway, and the strategies that can help fix US healthcare. . He told his guests, “We are not happy with healthcare costs and want to help.” The unmet need: a new conceptual framework.

Insurance 126

Insurance Pharmaceutical Companies Pharmaceutical Companies 126

PharmaShots

APRIL 4, 2023

PsO, RA, UC, CD, uveitis & hidradenitis suppurativa The results from a P-I PK bridging study evaluating adalimumab (50mg/mL) vs citrate-free HCF (100mg/mL) showed that the study met all of the primary objectives confirming similar safety, immunogenicity & PK of Hyrimoz 50mg/mL & the high-concentration formulation Sandoz continues to expand (..)

FDA 49

FDA 49

pharmaphorum

NOVEMBER 21, 2022

Although originally focused more on providers and health tech, the US conference HLTH has been steadily widening its scope and now hosts a wide variety of healthcare stakeholder. At this year’s conference in Las Vegas, several pharma companies announced news at the show. Here’s a roundup of major pharma news out of HLTH.

Department of Veterans Affairs 52

Department of Veterans Affairs Medical Records Communication Hospitals 52

pharmaphorum

JANUARY 5, 2021

Haven, the healthcare venture launched by Amazon, Berkshire Hathaway and JP Morgan Chase is to cease trading next month after failing to achieve its goal of pushing down health insurance costs for US workers. The venture had sought to “transform healthcare” while also cutting costs for hundreds of thousands of workers.

Insurance 69

Insurance 69

pharmaphorum

NOVEMBER 4, 2021

The Medicines and Healthcare products Regulatory Agency (MHRA) said today that molnupiravir, now given the trade name Lagevrio, is safe and effective at reducing the risk of hospitalisation and death in these patients. The US government meanwhile has ordered 1.7 pic.twitter.com/FCMRkMiUP9.

Hospitals 98

Hospitals Compounding 98

PharmaShots

APRIL 3, 2023

Shots: The US FDA has approved Hyrimoz (adalimumab-adaz) high-concentration formulation, a biosimilar to Humira (adalimumab) for 7 indications incl. RA, JIA, PsA, AS, CD, UC and PsO.

FDA 40

FDA 40

Fuld

APRIL 15, 2021

In just three years, Amazon has put together a package of leading-edge services that have the potential to revolutionize the US healthcare market. The major global brand is now maximizing the use of technology to allow patients to continue to use telemedicine to interact with providers on their time and in their preferred location.

Health and Personal Care Stores 96

Health and Personal Care Stores Cerner Packaging Customer Service 96

Pharmaceutical Technology

MAY 26, 2023

This news follows the recent application acceptance by the US Food and Drug Administration and supports our continued commitment to providing expanded access to life-changing treatments while also helping over-burdened healthcare systems generate savings.”

Packaging 52

Packaging 52

pharmaphorum

DECEMBER 4, 2020

The Wall Street Journal reported the news first, quoting an unnamed source directly involved in the development that some early batches of raw materials had failed to meet standards, causing production delays. Of those 85-100 million will be available in the US and 15-25 million will be available outside the US. million doses.

Vaccines 112

Vaccines Documentation FDA 112

PQA

APRIL 7, 2023

Thrifty White is a technology-enabled healthcare services company focused on utilizing patient engagement to improve outcomes and reduce the cost of care. Solidify Your Plans to Join Us in Nashville! PQA also offers a special 4-hour, pre-meeting workshop, Medication Use Quality Live, accredited for 0.4 hours of pharmacy CE.

Medication Delivery 52

Medication Delivery 52

Pharmaceutical Technology

JULY 6, 2022

Talks of a bear market in the biotech sector do not seem to pass, with news of companies falling into administration and layoffs becoming a recurrence. According to Skillington, the Covid-19 pandemic saw heavy investment in healthcare, and there is likely a certain switch to other directions. Weathering a storm of uncertainty.

129

129

Pharmaceutical Technology

JULY 20, 2022

On 6 July, in an effort to accelerate access, the US Food and Drug Administration (FDA) allowed pharmacists to also begin prescribing the drug to eligible individuals with Covid-19. And, if there are concerns, the pharmacist can call their healthcare provider to develop a plan. Paxlovid in the news.

Labelling 111

Labelling Community Pharmacies Medical Records FDA 111

pharmaphorum

MARCH 3, 2022

. “We believe that this is the first time that a large biopharmaceutical company and a digital health company are collaborating to commercialise digital health solutions in the US market,” said Erez Raphael, Dario’s chief executive.

91

91

PQA

APRIL 5, 2024

Finalize Your Plans for the 2024 PQA Annual Meeting Finalize your plans to join us in Baltimore! Join Micah Cost for a leadership conversation and network with other healthcare quality leaders. We are looking forward to connecting with you all to discuss our shared goals to advance medication use quality. Make plans to join us!

Specialty Pharmacies 40

Specialty Pharmacies Community Pharmacies 40

pharmaphorum

SEPTEMBER 14, 2020

A UK safety committee has concluded its investigations and recommended to the country’s Medicines and Healthcare products Regulatory Agency (MHRA) that trials are safe to resume. UK health secretary Matt Hancock welcomed the news in a tweet, saying it is “good news” that the trials are back up and running.

Vaccines 83

Vaccines Immunization 83

PQA

NOVEMBER 17, 2023

If you have news you'd like for us to spotlight in an upcoming Five For Friday, send us an email! -- Richard Schmitz, PQA Chief Engagement Officer Incorporating Equity into Clinical AI Tools Kedar Mate, president and CEO of the Institute for Healthcare Improvement, spoke about the importance of incorporating equity into clinical AI tools.

Vaccines 59

Vaccines 59

PQA

MARCH 10, 2023

We also highlight our members' perspectives on health equity, improving equity data and rural healthcare. The PQA Quality Forum Webinar is a regular, recurring series on healthcare quality topics with a focus on medication use and medication services. Join us May 10-12 in Nashville, Tenn.

Community Pharmacies 52

Community Pharmacies Patient Care 52

pharmaphorum

AUGUST 7, 2020

The US government has selected a potential vaccine from Sanofi and GlaxoSmithKline for its Operation Warp Speed COVID-19 vaccine development initiative, committing up to $2.1 to just under €4 billion, “weighed down” by COVID-19 and China’s new volume-based procurement policy for healthcare products.

Nursing Homes 104

Nursing Homes Vaccines Immunization Hospitals 104

Pharmaceutical Technology

JULY 6, 2022

Talks of a bear market in the biotech sector do not seem to pass, with news of companies falling into administration and layoffs becoming a recurrence. According to Skillington, the Covid-19 pandemic saw heavy investment in healthcare, and there is likely a certain switch to other directions. Ori raised over $100 million (EUR97.52

64

64

The Checkup by Singlecare

JANUARY 3, 2024

This GLP-1 receptor triggers brain and metabolic actions to help us release insulin from our pancreas, limit the release of stored glucose in our bodies, slow down our digestive systems, and, ultimately, lets our brains know we have eaten and are full.” Strange side effects, such as Ozempic face and Ozempic butt have also made the news.

Dosage 105

Dosage Documentation Compounding Labelling 105

pharmaphorum

JUNE 9, 2021

At Fishawack Health, we are always seeking opportunities to enhance our capabilities and help our life science clients navigate the new, dynamically changing healthcare environment. And that’s why we are excited to welcome Chicago-based closerlook LLC to our pack. Meet closerlook.

Communication 56

Communication 56

Pharmaceutical Technology

APRIL 28, 2023

Otsuka America Pharmaceutical and Lundbeck have received approval from the US Food and Drug Administration (FDA) for a new drug application for Abilify Asimtufii (aripiprazole) to treat schizophrenia or for maintenance monotherapy treatment of bipolar I disorder in adult patients.

FDA 52

FDA Labelling 52

DiversifyRx

DECEMBER 22, 2022

All of us despise PBMs. If you are truly interested in learning how to expand your revenue streams outside the control of PBMs, we suggest you join us at one of our Pharmacy Profit Summits in Orlando in February or Dallas in August. I n A World Without PBMS – I am sorry to be the bearer of bad news.

Independent Pharmacies 98

Independent Pharmacies Insurance Patient Care 98

Pharmaceutical Technology

MARCH 23, 2023

This week, the Medicines and Healthcare products Regulatory Agency (MHRA) is introducing major changes to clinical trial regulation in the UK with expedited timelines at several stages. The MHRA hopes this new framework “will remove obstacles to innovation” and “streamline the regulation of clinical trials” amongst other things.

59

59